8,683 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Aristides Capital LLC

Aristides Capital LLC bought a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 8,683 shares of the company’s stock, valued at approximately $241,000.

Several other hedge funds also recently made changes to their positions in OPCH. Algert Global LLC grew its holdings in Option Care Health by 12.4% in the 2nd quarter. Algert Global LLC now owns 197,797 shares of the company’s stock worth $5,479,000 after acquiring an additional 21,853 shares during the last quarter. Mackenzie Financial Corp boosted its holdings in shares of Option Care Health by 7.2% during the second quarter. Mackenzie Financial Corp now owns 45,782 shares of the company’s stock worth $1,268,000 after purchasing an additional 3,070 shares during the period. The Manufacturers Life Insurance Company increased its holdings in Option Care Health by 16.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,759,061 shares of the company’s stock valued at $48,726,000 after purchasing an additional 244,876 shares during the period. Dark Forest Capital Management LP bought a new position in Option Care Health during the 2nd quarter valued at approximately $210,000. Finally, Deerfield Management Company L.P. Series C purchased a new stake in Option Care Health in the 2nd quarter worth approximately $300,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Trading Down 0.4 %

OPCH opened at $31.30 on Tuesday. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. Option Care Health, Inc. has a 52 week low of $26.11 and a 52 week high of $34.63. The stock has a market cap of $5.44 billion, a PE ratio of 20.59, a PEG ratio of 2.42 and a beta of 1.29. The business has a 50 day moving average of $31.29 and a 200-day moving average of $30.40.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. The firm had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The company’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.63 EPS. Equities research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday. Barrington Research boosted their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.